Purchase of production of pigment yellow 83, [bisphenyl-14C(U)]- and pigment red 22, [phenyl-14C(U)]- (RADIOLABELING)
Ended Purchase Order Awarded Last action
- Contract number
- 75F40120P00022
- Awardee
-
Moravek Biochemicals, Inc. UEI D5UNRH3YCMD1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $64,811
Award facts
- Opportunity
-
- Purchase of Pigment Yellow 83, [Bisphenyl-14C(U)]- and Pigment Red 22, [Phenyl-14C(U)]- (radiolabeling) Solicitation · FDARFQ1221566 · Posted Oct 29, 2019
- Contract value 100% obligated
- $64,811.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Brea, CA 92821, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $64.8K firm fixed-price purchase order to Moravek Biochemicals, Inc., a small business concern located in Brea, California, on December 26, 2019. The contract, designated as a Total Small Business set-aside, calls for the production of radiolabeled pigment compounds—specifically Pigment Yellow 83 with bisphenyl-14C labeling and Pigment Red 22 with phenyl-14C labeling. These radiolabeled materials are used in pharmaceutical research and regulatory applications to track the distribution and metabolism of compounds within biological systems. The work was completed by the March 26, 2020 deadline.
Moravek Biochemicals brings specialized expertise in custom radiolabeling and Good Manufacturing Practice-compliant production of carbon-14 labeled active pharmaceutical ingredients. The company, registered in SAM.gov since 1997 and structured as a Subchapter S Corporation, has established a consistent track record serving the FDA and other federal research agencies with highly precise radiolabeled compounds. This award reflects the company's capability to deliver complex, specification-driven scientific manufacturing services within the contract ceiling value.
Quick answers
Who was awarded contract 75F40120P00022?
75F40120P00022 was awarded to Moravek Biochemicals, Inc. by Food and Drug Administration (Department of Health and Human Services) on December 26, 2019.
How much is contract 75F40120P00022 worth?
The government has obligated $64,811 on 75F40120P00022.
Was contract 75F40120P00022 competed?
The extent of competition for 75F40120P00022 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award